4/16/2010

Akorn said it obtained FDA approval for its generic version of pain drug Dilaudid-HP and will begin to distribute the product next month. The approval comes as Akorn starts producing an injectable formulation of the antibiotic vancomycin HCL through a joint venture with Strides Arcolab.

Related Summaries